共 50 条
- [41] Indications for the use of pertuzumab in non-metastatic HER2-positive breast cancer in the neoadjuvant and adjuvant. Review of the literature and therapeutic approach at the Instituto Nacional de Cancerologia - Colombia REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 : 16 - 25
- [42] Follow-up of the patient with breast cancer history. Review of the evidence and approach at the Instituto Nacional de Cancerologia - Colombia REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 : 52 - 71
- [50] Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer LANCET ONCOLOGY, 2023, 24 (06): : E238 - E238